Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zomedica's ebitda for the twelve months ending Dec 31, 2020 was -$16.46M. For fiscal 2020 it was -$16.46M. The highest annual figure on record is -$5.68M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$16.46M | – |
| FY2019 | Dec 31, 2019 | -$19.51M | – |
| FY2018 | Dec 31, 2018 | -$16.38M | – |
| FY2017 | Dec 31, 2017 | -$7.99M | – |
| FY2016 | Dec 31, 2016 | -$5.68M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -$5.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.50M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.22M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.26M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.78M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.32M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.63M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.36M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.13M | – |
See a number that looks wrong?